Regulatory Reply to the ATMOSPHERE Data Monitoring Committee
N Engl J Med
.
2016 Apr 21;374(16):1585-6.
doi: 10.1056/NEJMc1603514.
Epub 2016 Apr 4.
Authors
Tomas Salmonson
1
,
Heidi Janssen
2
,
Thomas Sudhop
3
,
Elke Stahl
3
Affiliations
1
Medical Products Agency, Uppsala, Sweden tomas.salmonson@mpa.se.
2
European Medicines Agency, London, United Kingdom.
3
Federal Institute for Drugs and Medical Devices, Bonn, Germany.
PMID:
27043362
DOI:
10.1056/NEJMc1603514
No abstract available
Publication types
Letter
Comment
MeSH terms
Amides / adverse effects*
Clinical Trials Data Monitoring Committees*
Diabetes Mellitus, Type 2 / drug therapy*
Fumarates / adverse effects*
Humans
Randomized Controlled Trials as Topic*
Substances
Amides
Fumarates